[go: up one dir, main page]

Sebag et al., 1992 - Google Patents

Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy

Sebag et al., 1992

View PDF
Document ID
7160408563207981106
Author
Sebag J
Buckingham B
Charles M
Reiser K
Publication year
Publication venue
Archives of ophthalmology

External Links

Snippet

• Vitreous changes in diabetes can exacerbate proliferative diabetic retinopathy. These changes may be due to the effects of diabetes on vitreous collagen. Vitreous samples from 19 patients with proliferative diabetic retinopathy and 23 patients without diabetes were …
Continue reading at www.vmrinstitute.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition

Similar Documents

Publication Publication Date Title
Sebag et al. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy
Sebag et al. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy.
Lieber et al. Contractile and cellular remodeling in rabbit skeletal muscle after cyclic eccentric contractions
Campochiaro et al. Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown
Reddy Glucose‐mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues
Evereklioglu et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration
Najibi et al. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery
Keltner et al. Management and monitoring of cancer-associated retinopathy
Obrenovitch et al. Extracellular neuroactive amino acids in the rat striatum during ischaemia: comparison between penumbral conditions and ischaemia with sustained anoxic depolarisation
KR100528664B1 (en) Composition for Diagnosing Diabetic Retinopathy and a kit for Diagnosing Diabetic Retinopathy comprising the same
Odetti et al. Age-related increase of collagen fluorescence in human subcutaneous tissue
Spiro et al. Increased rat myocardial type VI collagen in diabetes mellitus and hypertension
Suzuki et al. Age-related alterations in myosin heavy chain isoforms in rat intrinsic laryngeal muscles
Gealekman et al. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen
Dong et al. Characterization of the biologic activities of a recombinant human zona pellucida protein 3 expressed in human ovarian teratocarcinoma (PA-1) cells
JP5345929B2 (en) Cyclic alpha-conotoxin peptide
JP2004512287A (en) Use of a retinal cell apoptosis inhibitor for the prevention or treatment of diabetic retinopathy
Gottlieb et al. Mechanosensitive ion channels as drug targets
Devanand et al. Effects of electroconvulsive therapy on plasma GABA
Streeten The nature of the ocular zonule
EP1003458B1 (en) Liver function test
Ranga et al. Age-related changes in elastic fibers and elastin of lung
Takemoto et al. Covalent changes in MIP26K during aging of the human lens membrane.
Nagaraj et al. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen
Helbig et al. Life expectancy of diabetic patients undergoing vitreous surgery.